Your browser is no longer supported. Please, upgrade your browser.
Settings
MOTS Motus GI Holdings, Inc. daily Stock Chart
MOTS [NASD]
Motus GI Holdings, Inc.
Index- P/E- EPS (ttm)-1.76 Insider Own0.30% Shs Outstand20.50M Perf Week0.69%
Market Cap89.58M Forward P/E- EPS next Y-1.01 Insider Trans- Shs Float15.63M Perf Month36.56%
Income-20.90M PEG- EPS next Q-0.32 Inst Own46.10% Short Float2.49% Perf Quarter2.58%
Sales0.05M P/S1990.78 EPS this Y-148.00% Inst Trans41.61% Short Ratio5.48 Perf Half Y-41.11%
Book/sh0.60 P/B7.28 EPS next Y25.70% ROA- Target Price10.50 Perf Year-
Cash/sh0.57 P/C7.72 EPS next 5Y- ROE- 52W Range2.34 - 10.66 Perf YTD40.51%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-59.01% Beta-
Dividend %- Quick Ratio5.20 Sales past 5Y- Gross Margin- 52W Low86.74% ATR0.34
Employees39 Current Ratio5.20 Sales Q/Q- Oper. Margin- RSI (14)71.56 Volatility7.12% 12.19%
OptionableNo Debt/Eq0.00 EPS Q/Q-9.30% Profit Margin- Rel Volume0.82 Prev Close4.36
ShortableYes LT Debt/Eq0.00 EarningsFeb 13 BMO Payout- Avg Volume71.03K Price4.37
Recom- SMA2028.63% SMA5027.94% SMA200-12.74% Volume57,930 Change0.23%
Aug-30-18Initiated Ladenburg Thalmann Buy $14.50
Aug-28-18Initiated Dougherty & Company Buy $8
Jan-03-19 08:30AM  Motus GI Announces Publication of Pure-Vu® System Clinical Study Data in Peer-Reviewed Endoscopy Journal Business Wire
Jan-02-19 08:30AM  Motus GI to Present at Biotech Showcase 2019 Business Wire +7.72%
Dec-19-18 08:00PM  Motus GI Announces $13.5 Million Follow-on Public Offering Business Wire
Dec-17-18 04:17PM  Motus GI Announces Launch of Proposed Follow-on Public Offering Business Wire -5.60%
Dec-05-18 08:37AM  What Kind Of Shareholder Appears On The Motus GI Holdings Incs (NASDAQ:MOTS) Shareholder Register? Simply Wall St.
Nov-20-18 08:00AM  Motus GI to Present at the Piper Jaffray Healthcare Conference Business Wire -7.58%
Nov-15-18 10:00AM  Orchestra BioMed Announces Completion of $41 Million Financing GlobeNewswire
Nov-14-18 07:35AM  Motus GI Reports 2018 Third Quarter Financial Results and Provides Business Update Business Wire
Nov-08-18 08:00AM  Motus GI Announces Successful Clinical Use of Pure-Vu® Slim Sleeve with Slim Colonoscopes Business Wire
Oct-10-18 08:05AM  Motus GI Presents Positive Clinical Data from U.S. Prospective Study of the Pure-Vu® System at the 2018 American College of Gastroenterology (ACG) Annual Meeting Business Wire
Oct-09-18 12:00PM  Orchestra BioMed Adds Three Industry Leaders to Strategic Advisory Board GlobeNewswire
Oct-08-18 09:00AM  Orchestra BioMed Bolsters Leadership Team with Appointment of Inessa Wheeler as Vice President, Strategy and Marketing GlobeNewswire
Oct-01-18 08:05AM  Motus GI to Present at the Ladenburg Thalmann 2018 Healthcare Conference Business Wire
Sep-25-18 07:00AM  Motus GI Appoints Medical Device Commercial Leader Timothy P. Moran as Chief Executive Officer; Mark Pomeranz Continues in Key Executive Leadership Role as President and Chief Operating Officer Business Wire
Sep-14-18 12:17PM  Is Motus GI Holdings Incs (NASDAQ:MOTS) Balance Sheet A Threat To Its Future? Simply Wall St. -5.47%
Sep-13-18 08:00AM  Motus GI Receives FDA Clearance to Market Pure-Vu® Slim Sleeve for Use with Slim Colonoscopes Business Wire +5.03%
Aug-14-18 08:05AM  Motus GI Reports 2018 Second Quarter Financial Results and Provides Business Update Business Wire
Aug-09-18 08:35AM  Motus GI Appoints Jeff Hutchison as VP of U.S. Sales and Commercial Operations Business Wire
Jul-30-18 08:05AM  Motus GI Strengthens IP Portfolio with Issuance of Japanese Patent for the Pure-Vu® System Business Wire -5.13%
Jun-25-18 07:05AM  Motus GI Announces Inclusion in the Russell Microcap® Index Business Wire +8.05%
Jun-04-18 07:35AM  Motus GI Presents Cost Analysis Data Demonstrating Pure-Vu® System Has the Potential to Reduce Costs and Incidence of Colorectal Cancer at Digestive Disease Week® 2018 Business Wire +5.44%
May-23-18 07:35AM  Motus GI Enrolls First Patient in REDUCE Study of the Pure-Vu® System in Hospitalized Patients Business Wire
May-21-18 07:35AM  Motus GI Announces Issuance of Chinese Patent for the Pure-Vu® System Business Wire -6.74%
May-15-18 07:35AM  Motus GI Reports 2018 First Quarter Financial Results and Provides Business Update Business Wire
May-10-18 08:05AM  Motus GI to Present Data at Digestive Disease Week® 2018 Showing Pure-Vu® System May Reduce Costs and Incidence of Colorectal Cancer Business Wire -5.79%
Apr-16-18 08:05AM  Motus GI Bolsters Medical Advisory Board with Appointment of Seth A. Gross, MD, FACG, FASGE, AGAF Business Wire
Mar-29-18 07:05AM  Motus GI Announces 2017 Financial Results and Provides Business Outlook Business Wire
Mar-27-18 07:35AM  Motus GI Expands Intellectual Property Portfolio with New U.S. Patent Issuance for the Pure-Vu® System Business Wire
Mar-20-18 08:05AM  Motus GI Announces Issuance of European Patent for the Pure-Vu® System Business Wire
Mar-13-18 08:35AM  Motus GI to Present at the Oppenheimer 28th Annual Healthcare Conference Business Wire
Feb-27-18 07:30AM  Motus GI Receives CE Mark Approval for the Pure-Vu® System Business Wire +5.13%
Feb-20-18 08:00AM  Motus GI Announces NASDAQ Closing Bell Ceremony Marketwired
Feb-16-18 04:05PM  Motus GI Announces Closing of Initial Public Offering Marketwired -6.98%
12:00PM  Motus GI Holdings, Inc. (Nasdaq: MOTS) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire
Feb-14-18 11:39AM  Motus shares slide 8% in trading debut MarketWatch
10:37AM  Medical device company Motus prices IPO at $5, low end of range MarketWatch
Motus GI Holdings, Inc. operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company is based in Fort Lauderdale, Florida.